Creo Medical Group PLC
LSE:CREO
Creo Medical Group PLC
LSE:CREO
Price:
11.75
GBX
-3.09%
Market Cap:
£48.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Creo Medical Group PLC
LSE:CREO
|
UK |
|
Stride Property Ltd
NZX:SPG
|
NZ |
|
Sumco Corp
TSE:3436
|
JP |
Cash Flow Statement
Cash Flow Statement
Creo Medical Group PLC
Creo Medical Group PLC
Currency: GBP
| Jun-2018 | Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||
| Net Income |
(8)
|
(15)
|
(14)
|
(16)
|
(17)
|
(20)
|
(21)
|
(25)
|
(28)
|
(27)
|
(25)
|
(22)
|
(22)
|
(29)
|
1
|
|
| Depreciation & Amortization |
0
|
0
|
1
|
1
|
1
|
2
|
2
|
3
|
3
|
3
|
3
|
3
|
4
|
3
|
1
|
|
| Stock-Based Compensation |
0
|
2
|
1
|
2
|
2
|
1
|
0
|
3
|
3
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Other Non-Cash Items |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(3)
|
(4)
|
(2)
|
(2)
|
(2)
|
(2)
|
2
|
2
|
|
| Cash Taxes Paid |
(2)
|
(2)
|
0
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(4)
|
(4)
|
(5)
|
(4)
|
(2)
|
(3)
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Change in Working Capital |
2
|
1
|
2
|
5
|
2
|
5
|
1
|
(1)
|
0
|
1
|
(1)
|
(1)
|
0
|
2
|
(1)
|
|
| Cash from Operating Activities |
(7)
N/A
|
(14)
-104%
|
(13)
+7%
|
(12)
+11%
|
(16)
-35%
|
(16)
-2%
|
(19)
-16%
|
(26)
-38%
|
(29)
-12%
|
(25)
+15%
|
(24)
+2%
|
(22)
+11%
|
(20)
+7%
|
(22)
-11%
|
3
N/A
|
|
| Investing Cash Flow | ||||||||||||||||
| Capital Expenditures |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(6)
|
(8)
|
(3)
|
(2)
|
(2)
|
(2)
|
(0)
|
(0)
|
|
| Other Items |
0
|
0
|
0
|
0
|
0
|
(20)
|
(20)
|
(2)
|
(2)
|
(3)
|
(19)
|
(17)
|
16
|
16
|
(3)
|
|
| Cash from Investing Activities |
(1)
N/A
|
(1)
-55%
|
(0)
+62%
|
(1)
-66%
|
(1)
-36%
|
(21)
-1 813%
|
(21)
-1%
|
(8)
+63%
|
(9)
-18%
|
(6)
+35%
|
(21)
-253%
|
(18)
+14%
|
14
N/A
|
15
+10%
|
(3)
N/A
|
|
| Financing Cash Flow | ||||||||||||||||
| Net Issuance of Common Stock |
0
|
46
|
46
|
49
|
49
|
0
|
0
|
34
|
34
|
0
|
32
|
32
|
0
|
11
|
11
|
|
| Net Issuance of Debt |
0
|
0
|
(0)
|
(0)
|
(0)
|
1
|
(0)
|
(2)
|
(1)
|
0
|
(1)
|
(2)
|
5
|
5
|
(1)
|
|
| Other |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
1
N/A
|
46
+9 167%
|
46
-1%
|
49
+7%
|
49
0%
|
1
-97%
|
0
-99%
|
32
+376 288%
|
34
+5%
|
0
-99%
|
31
+7 594%
|
30
-3%
|
5
-84%
|
16
+245%
|
10
-38%
|
|
| Change in Cash | ||||||||||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
|
| Net Change in Cash |
(7)
N/A
|
31
N/A
|
32
+5%
|
36
+13%
|
32
-12%
|
(36)
N/A
|
(40)
-11%
|
(2)
+96%
|
(4)
-186%
|
(30)
-583%
|
(15)
+52%
|
(10)
+31%
|
(2)
+84%
|
9
N/A
|
11
+13%
|
|
| Free Cash Flow | ||||||||||||||||
| Free Cash Flow |
(8)
N/A
|
(16)
-100%
|
(14)
+11%
|
(13)
+7%
|
(17)
-34%
|
(17)
+3%
|
(19)
-16%
|
(32)
-65%
|
(37)
-14%
|
(28)
+23%
|
(26)
+7%
|
(23)
+11%
|
(22)
+6%
|
(23)
-4%
|
3
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
